Roche nearing $5 billion deal to acquire Spark Therapeutics: WSJ

Roche nearing $5 billion deal to acquire Spark Therapeutics: WSJ
FILE PHOTO – The logo of Swiss pharmaceutical company Roche is seen outside the Shanghai Roche Pharmaceutical Co. Ltd. headquarters in Shanghai May 22, 2014. REUTERS/Aly Song (Reuters) – Swiss drugmaker Roche Holding AG is nearing a deal to acquire U.S. biotechnology company Spark Therapeutics Inc, the Wall Street Journal reported on Saturday, citing people familiar with the matter. The... Read More

Economic data, healthcare shares pressure Wall Street

Economic data, healthcare shares pressure Wall Street
(Reuters) – U.S. stocks edged lower on Thursday after a recent run of gains, pressured by weak economic data and a drop in healthcare shares, while investors kept a close watch on U.S.-China trade talks. Traders work on the floor of the New York Stock Exchange (NYSE) in New York, U.S., February 13, 2019. REUTERS/Brendan McDermid The Commerce Department said... Read More

Wall Street dragged down by healthcare stocks, weak economic data

Wall Street dragged down by healthcare stocks, weak economic data
(Reuters) – U.S. stocks fell on Thursday, pressured by weak economic data and a drop in healthcare shares led by Johnson & Johnson, with investors keeping a close watch on U.S.-China trade talks. Traders work on the floor of the New York Stock Exchange (NYSE) in New York, U.S., February 13, 2019. REUTERS/Brendan McDermid New orders for key U.S.-made capital... Read More

Bristol-Myers says Starboard nominated five directors, bought shares

Bristol-Myers says Starboard nominated five directors, bought shares
FILE PHOTO: Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near Agen, France March 29, 2018. REUTERS/Regis Duvignau/File Photo BOSTON (Reuters) – Bristol-Myers Squibb Co. said on Wednesday that activist hedge fund Starboard Value LP wants to add five directors to its board and bought one million shares after the... Read More

Exclusive: Bayer’s Monsanto wins arbitration ruling over royalties from Indian seed company

Exclusive: Bayer’s Monsanto wins arbitration ruling over royalties from Indian seed company
NEW DELHI (Reuters) – German drugmaker Bayer AG’s Monsanto unit has won proceedings against Indian seed maker Nuziveedu Seeds Ltd (NSL) in a royalty dispute, lawyers familiar with the matter said. FILE PHOTO: Monsanto is displayed on a screen where the stock is traded on the floor of the New York Stock Exchange (NYSE) in New York City, U.S. on... Read More

University of California to be granted pioneering CRISPR patent

University of California to be granted pioneering CRISPR patent
(Reuters) – The University of California will soon be granted a potentially valuable patent on the revolutionary gene-editing technology known as CRISPR, according to a document filed by the U.S. patent office on Friday. The U.S. Patent and Trademark Office decision to grant the patent could further fuel a long-running rivalry between the university and the Broad Institute, a biological... Read More

Explainer: Why Shanghai’s new Nasdaq-style tech board may be a game-changer

Explainer: Why Shanghai’s new Nasdaq-style tech board may be a game-changer
HONG KONG/SHANGHAI (Reuters) – The detailed rules for a Nasdaq-style start-up board in Shanghai have fueled hopes among early-stage companies the new regime could bring about positive changes in China’s stance towards raising equity that investors have been seeking. FILE PHOTO: A man stands on the Bund in front of Shanghai’s financial district of Pudong in Shanghai, China February 26,... Read More

U.S. sends 70 questions to WTO about China’s subsidies

U.S. sends 70 questions to WTO about China’s subsidies
GENEVA (Reuters) – The United States has accused China of hiding some trade-distorting subsidy programs from international scrutiny while disclosing others it does not need to, according to a document circulated on Wednesday at the World Trade Organization. FILE PHOTO: U.S. President Donald Trump, U.S. Secretary of State Mike Pompeo, U.S. President Donald Trump’s national security adviser John Bolton and... Read More

Amgen 2019 forecast falls short of expectations, shares dip

Amgen 2019 forecast falls short of expectations, shares dip
(Reuters) – Amgen Inc on Tuesday reported fourth-quarter profit that easily surpassed expectations as sales rose and tax expense fell, but competition for older medicines is growing and the drugmaker forecast 2019 earnings below Wall Street estimates. FILE PHOTO: An Amgen sign is seen at the company’s office in South San Francisco, California in this October 21, 2013 photo. REUTERS/Robert... Read More

Amgen quarterly profit tops Street view, 2019 forecast falls short

Amgen quarterly profit tops Street view, 2019 forecast falls short
FILE PHOTO: An Amgen sign is seen at the company’s office in South San Francisco, California in this October 21, 2013 photo. REUTERS/Robert Galbraith/File Photo (Reuters) – Amgen Inc on Tuesday reported higher-than-expected fourth-quarter profit as sales rose and tax expense fell, but competition for older medicines is growing and the drugmaker forecast 2019 earnings below Wall Street estimates. For... Read More